Compounding is a high-risk process unshielded from vulnerabilities, and one in which medication-errors do occur. The challenge to improve the safety of the compounding process has become the spotlight of the decade amidst recent tragedies in a post NECC compounding world. Root cause analysis is a reactive safety methodology widely used in the health-care industry for decades. As the name implies, this methodology retraces its steps geared to finding the origin or "root cause" of a critical error. In contrast, Failure Modes and Effects Analysis (FMEA) is a proactive safety methodology previously used by NASA, and the auto industry, and to a limited extent in the health-care industry. FMEA looks at a critical processes, and it assigns a risk score as a way to classify minute non-critical errors all the way to catastrophic errors, which would result in fatalities. FMEA is a useful safety methodology useful in high-risk processes (such as in compounding laboratories) aimed at identifying and preventing errors from occurring in the first place.
In response to USP <795> mandates our team at BIOSRX has developed a color-coded safety chart for topical hormone therapy designed to complement your error-reduction strategies and standard operating procedures. Please feel free to contact us for any questions at 800-280-9277 http://www.biosrx.com